California SB-729 Fertility Mandate: Billing Implications for IVF Clinics

California SB-729 took effect January 1, 2024, creating a new fertility coverage mandate for California-regulated health insurance plans. For IVF practices operating in California, SB-729 changed the landscape of who has coverage, what that coverage includes, and how claims must be structured to maximize reimbursement. The mandate extended coverage to thousands of patients who previously had none — same-sex couples, single individuals, and patients on large-employer plans that had previously excluded IVF. With new coverage comes a new set of billing requirements, authorization workflows, and denial patterns. Billing teams that treat SB-729 patients identically to patients on other commercial plans will encounter a predictable set of preventable errors: wrong plan-type determination, missing therapeutic donor insemination (TDI) documentation for same-sex couples, cycle limit miscounts, and authorization submissions routed to the wrong utilization management vendor.

What SB-729 Actually Requires

California SB-729, codified at Health and Safety Code Section 1374.55 and Insurance Code Section 10119.6, mandates coverage of medically necessary infertility treatment — including IVF — for qualifying California-regulated health plans. Specifically, the law requires: coverage for diagnosis and treatment of infertility; up to 3 complete oocyte retrievals per lifetime per enrollee; and fertility preservation services (egg cryopreservation, embryo cryopreservation, sperm cryopreservation) when medically necessary as a result of a condition or treatment that may cause iatrogenic infertility, including chemotherapy, radiation therapy, or surgery that would impair reproductive function. The law does not mandate coverage of elective fertility preservation for non-medical reasons — egg freezing for social, age-related, or career-related reasons is not required by SB-729.

Frozen embryo transfers (FETs) performed using embryos created during a covered IVF retrieval cycle are covered under the mandate, but plans have interpreted the benefit structure differently. Some plans treat FETs as included within the 3-retrieval lifetime limit (covering all transfers from each retrieval cycle without a separate count). Others authorize FETs as a separate covered service requiring standalone authorization. Because the statute does not specify FET terms with precision, confirm FET benefit structure for each California carrier at eligibility verification before the first claim is submitted.

Which Plans Must Comply With SB-729

This determination is the most consequential step in SB-729 billing — and the step most frequently skipped. The mandate applies only to fully insured large group health plans regulated by the California Department of Managed Health Care (DMHC) or the California Department of Insurance (CDI), covering 100 or more enrolled employees in the group, and issued, delivered, or renewed in California on or after January 1, 2024. Plans outside this definition are exempt from SB-729 coverage requirements regardless of whether the patient lives or receives care in California.

• Self-insured (self-funded, ASO) employer plans: exempt from SB-729 under ERISA preemption, regardless of employer size or state of operation. This is the most commonly missed exemption — large California employers in technology, entertainment, retail, and professional services frequently self-insure, and their employees carry Blue Shield of California, Anthem Blue Cross, or Health Net cards that do not indicate the plan is self-funded. Always confirm funding status by calling the carrier directly before assuming SB-729 compliance.
• Small group plans covering fewer than 100 enrolled employees: the 100-employee threshold applies to covered employees in the group, not the employer's total workforce headcount. An employer with 200 total employees that offers health coverage to 85 falls below the threshold. Verify the group size at eligibility verification — this information is available from the carrier.
• Individual market plans: SB-729 does not mandate IVF coverage for individual market plans purchased on or off Covered California. Covered California plans may carry fertility benefits under separate exchange requirements, but these are not SB-729 IVF mandates and the benefit terms differ.
• Medicare and Medi-Cal: federal health programs are not subject to California state insurance mandates. Medi-Cal does not cover IVF under any current provision.
• Grandfathered ACA plans: plans that have maintained grandfathered status under the Affordable Care Act may be exempt from new state coverage mandates, though grandfathered status is increasingly rare among active large group plans by 2024.

SB-729 Infertility Definition: Who Qualifies for Coverage

SB-729 explicitly extends IVF coverage to same-sex couples and single individuals — a substantial expansion from California's prior fertility coverage landscape and one that creates specific documentation requirements that differ from those for different-sex couples. The qualifying infertility definition is applied differently depending on the patient's relationship status and the available means of conception.

For people in different-sex relationships: infertility is defined as the inability to achieve pregnancy after 12 months of regular unprotected sexual intercourse without contraception, or after 6 months for women age 35 or older. For people in same-sex relationships or single individuals: infertility is defined as the inability to achieve pregnancy after 12 documented cycles of therapeutic donor insemination (TDI), or after 6 documented cycles for patients age 35 or older. The TDI documentation requirement is a direct billing implication. Before submitting an IVF prior authorization request for a same-sex couple or single patient, your practice must have on file documentation of the qualifying insemination cycles — including dates, cycle numbers, donor insemination method, and outcomes. Patients who completed TDI cycles at another clinic must obtain and transfer those records before the authorization package can be assembled. Missing TDI documentation is the leading cause of SB-729 IVF authorization denials for same-sex and single patient populations.

SB-729 Covered Services: CPT Codes and Billing Notes

The following table covers the primary CPT codes used in SB-729-mandated IVF billing. Embryology laboratory codes (89xxx series) are typically billed by the embryology lab under the clinic NPI or a separate laboratory tax ID, depending on the clinic's entity structure and carrier contracts. All codes must be authorized and billed with appropriate ICD-10 codes reflecting the documented infertility diagnosis.

Prior Authorization Pathways for California Carriers Under SB-729

Every California carrier providing IVF coverage under SB-729 requires prior authorization before any retrieval cycle begins. Submitting IVF claims without prior authorization is the most reliable way to generate an unappealable denial — it will be rejected on procedural grounds regardless of clinical appropriateness. Carrier authorization pathways under SB-729 as of 2024 are as follows.

Blue Shield of California routes IVF prior authorization through AIM Specialty Health (a CVS Health subsidiary). Submit through the AIM Specialty Health provider portal at aimspecialtyhealth.com. Blue Shield of CA and AIM require clinical criteria documentation addressing the applicable infertility definition under SB-729, including TDI cycle documentation for same-sex couples and single patients. Anthem Blue Cross of California also delegates fertility prior authorization to AIM Specialty Health — submit through the same AIM portal, with Anthem as the payer. Anthem CA uses cycle tracking and ties each authorization to a specific retrieval cycle number. Health Net California maintains its own utilization management process for fertility authorization; submit IVF authorization requests through the Health Net provider portal. Kaiser Permanente California processes fertility authorizations internally — patients must receive a referral or recommendation from their KP primary care provider or OB/GYN before the fertility clinic can initiate a KP authorization request.

• Submit authorization requests a minimum of 7 to 10 business days before the anticipated cycle start. California law requires plans to respond to standard prior authorization requests within 5 business days, but building a buffer allows time to respond to requests for additional documentation without delaying the cycle.
• List all anticipated CPT codes in the authorization request: retrieval codes (58970), embryology codes (89250 or 89251, 89280 or 89281, 89258), ultrasound monitoring codes (76830), and laboratory codes (82670, 84144). Under California carriers, any code not listed in the authorization may deny on the claim even when the service is a covered benefit under SB-729.
• For same-sex couples and single patients, attach TDI cycle documentation to the authorization request at submission — do not wait for the carrier to request it. A list of treatment dates, cycle numbers, donor insemination method, and outcomes with the treating provider name is sufficient in most cases.
• Obtain and record the authorization approval number, the approved date range, the complete list of approved CPT codes, and the reviewer name before any cycle service is rendered. Missing authorization reference numbers are among the top five mechanical denial causes in California fertility billing.
• For fertility preservation due to iatrogenic infertility risk (oncology patients), submit authorization under the fertility preservation indication — not as an IVF cycle for infertility. Use the primary oncology diagnosis code (e.g., C50.xx for breast cancer) alongside Z31.62 (encounter for fertility preservation procedure). The clinical documentation must specify the iatrogenic infertility risk from the planned treatment to distinguish this from an elective preservation request.

ICD-10 Code Selection for SB-729 IVF Claims

California carriers review ICD-10 code selection under SB-729 because the diagnosis establishes which infertility definition applies and whether the documented clinical presentation supports coverage. Non-specific codes (N97.9) when a specific etiology is documented increase the likelihood of medical necessity documentation requests. The following table covers the most common SB-729 billing scenarios and the preferred code sets.

Cycle Counting and the 3-Retrieval Lifetime Limit

SB-729 requires coverage of up to 3 complete oocyte retrievals per enrollee per lifetime. Applying this limit in practice requires carrier-specific clarification and careful internal tracking. A retrieval cycle that proceeds to egg collection counts as one complete retrieval regardless of the outcome — whether or not fertilization occurs, whether or not viable embryos result, and whether or not a live birth is achieved. A stimulation cycle that is cancelled before the retrieval procedure — because follicle development was inadequate or the patient elected to stop — does not typically count as a complete retrieval, but confirm this with each carrier at verification because plans have interpreted this provision differently. Multiple FETs performed from embryos created during a single covered retrieval do not consume additional retrieval credits; only the retrieval event itself counts.

Practices are responsible for tracking the SB-729 retrieval cycle count for each California patient and disclosing the remaining benefit to the patient before each new cycle begins. When a patient has had prior IVF cycles covered under SB-729 at another clinic, or through a prior employer plan, those cycles may count against the lifetime limit depending on how the patient's current plan interprets prior-cycle history. Collect prior IVF cycle records at intake for all California patients with SB-729-eligible coverage. If a California carrier asserts that pre-SB-729 cycles (performed before January 1, 2024) count against the lifetime limit, this is a valid appeal basis — most carriers are not counting pre-mandate cycles, and those that do are applying the lifetime limit in a manner not required by the statute.

Common SB-729 Billing Errors and How to Prevent Them

• Billing a self-funded ASO plan as SB-729-mandate-compliant: IVF claims submitted to a self-funded plan as mandate-required will deny as a non-covered service if the employer's plan does not voluntarily include IVF. This is the highest-impact SB-729 billing error — it results in write-offs for services the patient expected to be covered. Prevention: confirm fully insured status at every initial eligibility call, document the response, and flag self-funded patients separately in your billing system.
• Missing TDI documentation for same-sex couple and single patient authorizations: authorization packages without qualifying insemination cycle records trigger supplemental documentation requests that delay authorization and may push the cycle start date. Prevention: create a patient-specific intake checklist for same-sex and single patients that includes TDI records retrieval as a required pre-authorization step with a defined responsible staff member.
• Routing FET authorization under the retrieval cycle auth number: FETs require standalone authorization under all SB-729-compliant California carriers. Using the IVF retrieval auth number for an FET claim generates a clinical inconsistency denial — the FET CPT codes (58976, 89352) fall outside the scope of the retrieval authorization. Prevention: build a mandatory FET authorization trigger into your cycle workflow that activates when PGT results are received, when a freeze-all cycle completes, or when a fresh cycle does not proceed to transfer.
• Counting a cancelled stimulation cycle against the SB-729 lifetime limit: incorrectly logging a cancelled cycle as a consumed retrieval means the patient is told they have fewer covered retrievals remaining than they actually do, and the practice may turn away a covered patient or collect an out-of-pocket payment that should have been billed to the plan. Prevention: define "complete retrieval" in your cycle tracking system to require an egg retrieval procedure date, and confirm each carrier's counting policy in writing.
• Using infertility codes for iatrogenic fertility preservation claims: applying N97.x codes to an oncology patient's pre-chemotherapy egg freeze triggers a medical necessity review under the infertility criteria, which the patient does not meet. The claim denies even though the iatrogenic preservation benefit is separately covered. Prevention: use the oncology primary diagnosis plus Z31.62 for all iatrogenic fertility preservation claims — never use infertility codes for this patient population.
• Authorization submitted directly to a carrier that has delegated fertility PA to AIM: submitting Blue Shield of California or Anthem Blue Cross CA IVF authorization directly to the carrier instead of through AIM Specialty Health results in no authorization being issued in AIM's system. When the claim adjudicates, AIM has no record of approval and the claim denies for lack of prior authorization. Prevention: build carrier-specific authorization routing into your workflow and audit it annually — carriers change vendor relationships.

Appealing SB-729 Coverage Denials

California fully insured plans are subject to robust external appeal rights through state regulatory agencies. Plans regulated by the DMHC (HMO, managed care) must comply with the Independent Medical Review (IMR) process administered by the DMHC. Plans regulated by the CDI (PPO, indemnity) have access to the CDI's independent review process. Both processes require exhaustion of the plan's internal appeal first — submit the written internal appeal to the carrier within 180 days of the denial notice. If the internal appeal is denied, the patient or provider may request an IMR through the DMHC or CDI. IMR decisions in California are binding on fully insured plans, which provides leverage that does not exist for self-funded ERISA-governed plans.

For SB-729 medical necessity denials, the appeal package should include: the complete clinical summary with infertility diagnosis and etiology; duration of infertility and prior treatment history; documentation satisfying the applicable infertility definition (including TDI cycle records for same-sex or single patients); applicable ASRM clinical practice guidelines; peer-reviewed literature supporting IVF for the patient's specific clinical presentation; and the treating physician's signed attestation of medical necessity. For same-sex couple and single patient denials based on TDI documentation deficiencies, supplement the appeal with complete insemination records from every treating clinic and a physician attestation confirming the patient's prior TDI cycle history. A concurrent peer-to-peer review request with the plan's medical director can resolve many SB-729 medical necessity denials without waiting for a formal internal appeal decision — request the peer-to-peer within 48 hours of the denial notice when the cycle is time-sensitive.